Anti-Ro/SSA Antibodies Have Potential to Predict ILD in SSc
VIENNA — Anti-Ro/SSA antibodies may help predict which patients with systemic sclerosis (SSc) are at a greater risk for interstitial lung disease (ILD) and may serve as a biomarker to guide screening, according to an analysis of data from a large European cohort. The researchers were led by Blaž Burja…
Read More
Recent Comments